Year: 2025

  Availability of the Q2 2025 Aide mémoire Paris, France – June 30, 2025. Sanofi announced today that its Q2 2025 Aide mémoire is available on the “Investors” page of the company’s website: Second quarter 2025 (sanofi.com) As for each quarter, Sanofi prepared this document to assist in the financial modelling of the Group’s quarterly results. This document includes a reminder on various non-comparable items, as well as the foreign currency impact and share count. Sanofi’s second quarter 2025 results will be published on July 31, 2025.     About Sanofi Sanofi is an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people...

Company announcement no. 37 / 2025Schindellegi, Switzerland – 30 June 2025 Trifork Group: Weekly report on share buyback On 28 February 2025, Trifork initiated a share buyback program in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buyback program runs from 4 March 2025 up to and including no later than 30 June 2025. For details, please see company announcement no. 7 of 28 February 2025. Under the share buyback program, Trifork will purchase shares for up to a total of DKK 14.92 million (approximately EUR 2 million). Prior to the launch of the share buyback, Trifork held 256,329 treasury shares, corresponding to 1.3% of the share capital. Under the program, the following transactions have been...

Geneva, Switzerland, June 30, 2025 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced the completion of its strategic investment in WeCan Group SA (“WECAN”), a Swiss blockchain and data compliance innovator by acquiring a 28.30% equity stake in the company. This investment marks a pivotal milestone in accelerating the development and deployment of quantum-resilient, blockchain-based security solutions across financial services, IoT infrastructure, and Web 3.0 ecosystems. A Strategic Alliance to Secure the Future of Finance and IoT With the transaction now complete, SEALSQ and WECAN will integrate their technologies to co-develop next-generation...

Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathyTwo phase 3 studies are currently underway testing riliprubart in people with CIDP as a potential first-in-class treatment Japanese Ministry of Health, Labour and Welfare decision adds to similar designations in the US and Europe, underscoring global regulatory recognition of the potential for riliprupart to address significant unmet medical needs for people living with this rare neurological conditionParis, June 30, 2025. The Ministry of Health, Labour and Welfare (MHLW) in Japan has granted orphan drug designation to riliprubart, a monoclonal antibody that selectively inhibits activated C1s in the classical complement pathway for people with chronic inflammatory demyelinating polyneuropathy (CIDP). Despite available therapies,...

GUANGZHOU, China, June 29, 2025 (GLOBE NEWSWIRE) — Last Friday, Singapore’s Acting Minister for Transport, Mr. Jeffrey Siow, led a high-level delegation to WeRide’s (Nasdaq: WRD) headquarters in Guangzhou, underscoring growing cooperation between the Ministry of Transport (MOT) and WeRide to advance autonomous mobility and strengthen Singapore’s public transport system. Accompanying Acting Minister Siow were Senior Minister of State for Transport Sun Xueling; leaders from the National Transport Workers Union, National Taxi Association, and National Private Hire Vehicles Association; as well as representatives from the MOT and the Land Transport Authority (LTA). The delegation was welcomed by Tony Han, Founder and CEO of WeRide; Jennifer Li, CFO and Head of International of WeRide; Kerry Xu, General Manager of...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces it will once again support select players during high profile matches at The Championships, Wimbledon in 2025. The world’s oldest and most prestigious tennis tournament serves as a perfect backdrop to showcase Smith+Nephew’s purpose of ‘Life Unlimited’ – making a difference in patients’ lives through the excellence of a diverse Sports Medicine product portfolio and the application of new technologies.Tennis is a high-impact sport that places great stress on various areas of the body – especially joints – often resulting in injury. Some of the latest technologies and solutions from Smith+Nephew for joint repair include:REGENETEN◊ Bioinductive Implant: With more than 150,000 procedures1 completed globally since its introduction in 2014, the REGENETEN...

PASCAGOULA, Miss., June 28, 2025 (GLOBE NEWSWIRE) — HII (NYSE: HII) christened today the future USS Jeremiah Denton (DDG 129), the third Flight III Arleigh Burke-class destroyer to be built at the company’s Ingalls Shipbuilding division. The ship’s name honors former U.S. Sen. Jeremiah Denton Jr., a Vietnam War veteran who was awarded the Navy Cross for his heroism as a prisoner of war. Denton spent 34 years as a naval aviator, including eight years as a prisoner of war in Vietnam. He is known for his act of genius during a televised broadcast in captivity, when Denton spelled out the word “torture” through Morse code using his eyes to blink the code. Following his Navy career, Denton was elected to the U.S. Senate representing his home state of Alabama in 1980. “Today, we honor the skilled work of our Ingalls shipbuilders and...

Vancouver, B.C., June 27, 2025 (GLOBE NEWSWIRE) — Trillion Energy International Inc. (“Trillion” or the “Company”) (CSE: TCF) (OTCQB: TRLEF) (Frankfurt: Z62), announces that it proposes to issue an aggregate of 7,725,908 common shares of the Company at $0.05 per share in settlement of $386,295.42 in debt owed by the Company to directors, officers and consultants of the Company (the “Debt Settlement“). The common shares will be subject to a four month and one day hold period from the date of issuance as per applicable Canadian securities legislation. In connection with the Debt Settlement, an aggregate of 3,900,000 common shares of the Company is being issued for certain management services from directors and officers of the Company (the “Insider Settlement“). The Insider Settlement is considered a “related-party...